Comments

Cidara Therapeutics (CDTX) Stock Price, Quote, News & History

CDTXNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$220.10

-0.55-0.25%

At close: Dec 15, 4:00 PM EST

$220.10

N/A

After Hours: 4:03 PM EST

Overview

News Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$220.45

$220.10

Volume / Avg.

1.32M / 1.43M

Day Range

$219.79 - $220.45

52 Wk Range

15.22 - 221.20

Market Cap

$6.92B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

6.73%

Days to Cover

1.04

Recent Cidara Therapeutics Inc News

Pfizer's New mRNA Flu Vaccine Outperforms Traditional Shot Against Predominant Strains

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side effects.

Vandana Singh

Top 2 Health Care Stocks That May Fall Off A Cliff This Month

Avi Kapoor

Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.6

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

$220.45

$220.10

Volume / Avg.

1.32M / 1.43M

Day Range

$219.79 - $220.45

52 Wk Range

15.22 - 221.20

Market Cap

$6.92B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

6.73%

Days to Cover

1.04

About

Sector

Health Care

Industry

Biotechnology

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprise...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry